Amendment · S5M-12856.2 · Session 5
Access to Vital Medicines
Amendment to S5M-12856 Access to Vital Medicines
The amendment
As an amendment to motion S5M-12856 in the name of Anas Sarwar (Access to Vital Medicines), insert at end "; acknowledges that patients need a trusted and transparent system for regulating the approval of all medicines; expresses concern that leaving the EU and single market will jeopardise patients’ access to medical treatment and clinical trials, and agrees that pharmaceutical companies must make every possible effort, in the interests of patients, to price products fairly and responsibly and share data as openly as possible."
Vote
No recorded vote on this amendment. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.
Other amendments
2-
No recorded vote
-
No recorded vote
Supporters
No MSP has added their name to this amendment.
In the Official Report
No contribution in the Official Report cites S5M-12856.2 by reference.